Background: Reliable measurement of phenylalanine (Phe) is a prerequisite for adequate follow-up of phenylketonuria (PKU) patients. However, previous studies have raised concerns on the intercomparability of plasma and dried blood spot (DBS) Phe results. In this study, we made an inventory of differences in (pre-)analytical methodology used for Phe determination across Dutch laboratories, and compared DBS and plasma results.

Methods: Through an online questionnaire, we assessed (pre-)analytical Phe measurement procedures of seven Dutch metabolic laboratories. To investigate the difference between plasma and DBS Phe, participating laboratories received simultaneously collected plasma-DBS sets from 23 PKU patients. In parallel, 40 sample sets of DBS spotted from either venous blood or capillary fingerprick were analyzed.

Results: Our data show that there is no consistency on standard operating procedures for Phe measurement. The association of DBS to plasma Phe concentration exhibits substantial inter-laboratory variation, ranging from a mean difference of -15.5% to +30.6% between plasma and DBS Phe concentrations. In addition, we found a mean difference of +5.8% in Phe concentration between capillary DBS and DBS prepared from venous blood.

Conclusions: The results of our study point to substantial (pre-)analytical variation in Phe measurements, implicating that bloodspot Phe results should be interpreted with caution, especially when no correction factor is applied. To minimize variation, we advocate pre-analytical standardization and analytical harmonization of Phe measurements, including consensus on application of a correction factor to adjust DBS Phe to plasma concentrations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932865PMC
http://dx.doi.org/10.1002/jmd2.12186DOI Listing

Publication Analysis

Top Keywords

dbs phe
16
phe
13
dbs
9
follow-up phenylketonuria
8
pku patients
8
dbs plasma
8
phe measurement
8
plasma dbs
8
phe concentration
8
phe measurements
8

Similar Publications

An off-the-shelf Agilent 7100 capillary electrophoresis (CE) instrument was employed for the automated processing and analysis of dried blood spots (DBSs) collected by Capitainer®B volumetric devices. Solutions for DBS elutions were transferred directly into CE vials through a separation capillary by the application of an auxiliary nitrogen gas connected to the external pressure line of the CE instrument. This allowed for liquid handling at pressures up to 15 bar and enabled the use of a single capillary for rapid DBS processing and efficient CE separations.

View Article and Find Full Text PDF

Background: Hyperphenylalaninemia (HPA) is defined as blood phenylalanine (Phe) levels exceeding the normal values (>120 μmol/L or >2 mg/dL) and is caused by a deficiency in the enzyme phenylalanine hydroxylase (PAH). The widespread screening of Phe levels in newborn screening programs has led to a very high number of patients with HPA.

Methods: The samples were collected at various ages, not at the point of diagnosis.

View Article and Find Full Text PDF

Satisfaction with home blood sampling methods and expectations for future point-of-care testing in phenylketonuria: Perspectives from patients and professionals.

Mol Genet Metab

May 2024

Laboratory of Metabolic Diseases, Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address:

Article Synopsis
  • - The study highlights significant dissatisfaction among PKU patients and professionals with current home sampling methods, particularly regarding sample collection frequency and lengthy turn-around times.
  • - A survey of 210 parents, 156 patients, and 95 professionals revealed that many patients take fewer samples than recommended, and there's a general sentiment of wanting better testing methods.
  • - There is strong interest in point-of-care testing (POCT), with 97% of parents willing to use a device, though concerns regarding cost, accuracy, and other factors were raised.
View Article and Find Full Text PDF

Measurement of plasma and dried blood spot (DBS) phenylalanine (Phe) is key to monitoring patients with phenylketonuria (PKU). The relationship between plasma and capillary DBS Phe concentrations has been investigated previously, however, differences in methodology, calibration approach and assumptions about the volume of blood in a DBS sub-punch has complicated this. Volumetric blood collection devices (VBCDs) provide an opportunity to re-evaluate this relationship.

View Article and Find Full Text PDF
Article Synopsis
  • Frequent blood phenylalanine (Phe) measurements are essential for monitoring phenylketonuria (PKU) patients, and there is a need for a reliable at-home collection method with low variability in results.* -
  • A new volumetric absorptive microsampling (VAMS) method was validated using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS), showing high correlation with traditional plasma sampling methods in a clinical study of PKU subjects.* -
  • The results indicated that VAMS is a dependable approach for measuring blood Phe levels in PKU patients, enabling effective monitoring of treatment progress.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!